WO2012116790A1 - Verschluss für eine spritze und herstellungsverfahren - Google Patents
Verschluss für eine spritze und herstellungsverfahren Download PDFInfo
- Publication number
- WO2012116790A1 WO2012116790A1 PCT/EP2012/000785 EP2012000785W WO2012116790A1 WO 2012116790 A1 WO2012116790 A1 WO 2012116790A1 EP 2012000785 W EP2012000785 W EP 2012000785W WO 2012116790 A1 WO2012116790 A1 WO 2012116790A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cap
- closure
- retaining ring
- syringe
- securing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D99/00—Subject matter not provided for in other groups of this subclass
- B29D99/0096—Producing closure members for containers, e.g. closure caps or stoppers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
- A61M2005/3104—Caps for syringes without needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M2005/3117—Means preventing contamination of the medicament compartment of a syringe
- A61M2005/3118—Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula
- A61M2005/312—Means preventing contamination of the medicament compartment of a syringe via the distal end of a syringe, i.e. syringe end for mounting a needle cannula comprising sealing means, e.g. severable caps, to be removed prior to injection by, e.g. tearing or twisting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw
Definitions
- the invention relates to a syringe according to the preamble of claim 1, a closure for a syringe according to the preamble of claim 4 and a method for producing a closure according to the preamble of claim 11.
- syringes preferably prefilled with a medical and / or pharmaceutical preparation, during its storage or before its use, it has a closure.
- This comprises a sealing cap which seals the needle hub and a securing cap which engages around the closure cap and is fastened to the needle hub via a retaining ring.
- the syringe which is preferably suitable and intended for medical purposes, is thus tightly closed during its storage by the closure cap in the region of the needle hub so that a preparation provided in the syringe does not escape and is not contaminated by externally penetrating substances and / or germs can be.
- Known closures are composed of separate parts.
- the safety cap and the cap are provided as separate parts. They are manufactured in separate process steps and assembled for assembly on the syringe. Since these are small parts, they can easily be lost. The separate production steps and the separate storage of the individual parts bring a significant logistical effort. Due to the additional necessary assembly step to assemble the separate parts of the closure, the production of the closure and thus also the syringe becomes more expensive.
- the object of the invention is therefore to provide a syringe, a closure and a method for producing the closure, which do not have the disadvantages mentioned.
- a closure with the features of claim 1 is provided.
- This is characterized in that at least the fuse cap and the cap are integrally formed. They are therefore jointly handled and storable, so that not one of the two parts can be lost, and these must not be assembled before or during a final assembly of the syringe. As a result, the logistical effort is significantly reduced, and it eliminates an additional production step.
- a closure for a syringe with the features of claim 4 is provided.
- This has a closure cap for sealing the syringe, a locking cap which surrounds the closure cap, a retaining ring for fastening the closure to the syringe and a securing ring which surrounds the retaining ring and to which the securing cap is detachably attached.
- the closure is characterized in that at least the cap and the safety cap are integrally formed. This results in the already mentioned in connection with the syringe advantages.
- a closure which is characterized in that the safety cap, the retaining ring and / or the retaining ring comprises a comparatively hard material / include.
- the fuse cap support the cap and in particular absorb forces that would otherwise possibly lead to an unintentional removal of the cap.
- the retaining ring and the retaining ring have the necessary stability in order to fulfill their retaining function if they comprise a hard material. More preferably, the hard material is a thermoplastic polymer, most preferably polypropylene. It is also preferred that the safety cap, the retaining ring and / or the retaining ring consist of the hard material, preferably the thermoplastic polymer, most preferably polypropylene.
- closure cap comprises a soft or elastic material.
- the soft or elastic material is preferably a thermoplastic elastomer (TPE).
- TPE thermoplastic elastomer
- the closure cap consists of the soft material, preferably of TPE.
- a closure in which the safety cap and the cap in a two-component ten injection molding process are made as a one-piece element.
- the securing cap from a comparatively hard and the closure cap from a comparatively soft or elastic material, wherein both are manufactured in one piece in one and the same process.
- a safety cap is injected from a first, preferably hard material.
- a closure cap is injected from a second, preferably soft material. Either the cap is sprayed onto the safety cap, or the safety cap is sprayed onto the cap. So ultimately it does not matter in which order the parts are molded by injection molding. It is essential that the safety cap and the cap are made in one piece from different materials, wherein the one element is molded to the other element in the injection molding process.
- the circlip is molded in the same multi-component injection molding process as the fuse cap and the cap.
- the securing ring can be molded onto the securing cap.
- the retaining ring is molded in the same multi-component injection molding process. This allows otherwise separate process steps to be integrated into a multi-component injection molding process.
- the safety cap, the retaining ring and preferably also the retaining ring are formed in one step from the same material.
- the entire closure is produced in the multi-component injection molding process as a one-piece element.
- a method is preferred in which the securing cap and the closure cap are locked together during injection molding.
- the safety cap is removed, the cap is taken from the safety cap when it is locked with it.
- the needle hub is then accessible in one step, and the safety cap and cap need not be removed separately.
- Figure 1 is a sectional view of an embodiment of a syringe with not completely attached closure, and a detailed view of the sectional view of a syringe in the closed state.
- 1 shows a representation of an embodiment of a syringe 1 in longitudinal section in a state in which a closure 3 is not yet fully seated on the syringe 1.
- the syringe 1 has a syringe barrel 5, which preferably receives a medical and / or pharmaceutical preparation.
- the syringe 1 is preferably used for medical purposes.
- the syringe cylinder 5 of the preferably prefilled syringe 1 is preferably closed by a stopper, not shown, in the region of a proximal end P. The stopper can be moved inside the syringe barrel 5 in order to expel the preparation via a needle hub 7 provided at a distal end D.
- needle hub serves to couple the syringe 1 with a dispensing means.
- this may be a needle or cannula.
- other delivery means as are conventional in the medical field, to the needle hub 7, for example a tube of an injection system or other medical device.
- the closure 3 comprises a closure cap 9, which is designed so that the needle attachment piece 7 can be closed in a sealing manner. It further comprises a safety cap 11, which surrounds the closure cap 9.
- the safety cap 11 is attached via a retaining ring 13 to the Nadelansatz Sharing.
- a locking ring 15 is provided, on which the fuse cap 11 is detachably attached.
- At least one of the securing cap 11 and the securing ring 15 is particularly preferred connecting tear-off provided, so that these elements are virtually interconnected via a predetermined breaking point.
- a plurality of tear-off webs-in the circumferential direction preferably distributed at an equal angular distance from each other-are provided, which connect the securing ring 15 and the securing cap 11 to one another.
- projections can be provided on the securing ring 15 and / or the securing cap 11, which projections extend in the direction of the other element.
- This support forces can be initiated when a shift of the fuse cap 11 and the locking ring 15 - in the longitudinal direction of the syringe 1, ie in the axial direction - to each other. This avoids that the tear-off webs accidentally break when axial compressive forces are introduced into the safety cap 11. On the other hand, they should tear as intended if axial tensile forces are introduced into the safety cap 11.
- the syringe 1 in the region of the needle hub 7 a fastening means preferably a groove, a bead or - as in the embodiment shown here - an undercut 17, by means of which the retaining ring 13 can be attached to the Nadelansatz Sharing 7.
- the retaining ring 13 can be attached to the Nadelansatz Sharing 7.
- it is pushed from above onto the needle hub 7 and engages below the undercut 17 a. It is then preferably no longer possible to remove it non-destructively.
- the circlip 15 has a preferably annular, radially inwardly projecting projection 19, with which he in up- set state behind an undercut 21 on the retaining ring 13 engages. In the exemplary embodiment shown in FIG. 1, it is therefore also preferably pushed onto the retaining ring 13 from above and finally engages with the projection 19 behind the undercut 21. It is then preferably no longer possible to separate the retaining ring 15 nondestructively from the retaining ring 13. Therefore, the safety cap 11 ruptures in the region of the at least one tear-off web from the securing ring 15 when axial tensile forces are introduced into it.
- the needle hub 7 is preferably formed as a cone, most preferably as a Luer cone.
- the retaining ring 13 preferably comprises a in the direction of the Nadelansatz Sharings 7, ie in the axial direction extending wall portion 23 which is formed in the illustrated embodiment as a thread, preferably as a Luer thread.
- a thread preferably as a Luer thread.
- closure cap 9 and the safety cap 11 are integrally formed. In this way, both elements can be handled together and stored together.
- the closure cap 9 preferably comprises a soft material; it preferably consists of this.
- the material is preferably softer or more elastic than the material of the needle hub 7.
- the cap 9 is preferably stretched elastically so that it rests sealingly against the needle hub 7. It preferably has a central projection 25, which in the mounted state in sealing engagement with an orifice 27 of the Nadelansatz Sharings 7 comes to further increase the sealing effect.
- the soft or elastic material is preferably a thermoplastic elastomer (TPE).
- TPE thermoplastic elastomer
- TPE-V crosslinked thermoplastic elastomer
- the closure 3 and the entire syringe 1 are preferably designed such that the medical and / or pharmaceutical preparation comes into contact exclusively with materials which are suitable for primary contact.
- the needle hub 7 preferably comprises glass or preferably consists of this.
- a preferably hard plastic is used as material for the needle hub 7. This is preferably formed integrally with the syringe barrel 5 and particularly preferably comprises the same material as this.
- the safety cap 11 preferably comprises a comparatively hard material or preferably consists of this material.
- the material is preferably harder than the material of the closure cap 9 so that the safety cap 11 can support it and absorb forces introduced into it. It also serves to protect the cap 9 from external forces acting on it so that it is not accidentally removed.
- the hard material is preferably a thermoplastic polymer, more preferably polypropylene.
- the locking ring 15 and preferably also the retaining ring 13 comprise a comparatively hard material or consist of this. Particularly preferably, they comprise or consist of the same material as the safety cap 11.
- the securing ring 15 and the retaining ring 13 can fulfill their securing or holding function particularly well if they consist of a comparatively hard material.
- the material of the retaining ring 13 is at least slightly more elastic than the material comprising the Nadelansatz- piece 7.
- the retaining ring 13 is at least slightly more elastic than the material comprising the Nadelansatz- piece 7.
- the inner diameter of the retaining ring 13 is suitably matched to the outer diameter of the syringe 1 in the region in Figure 1 below the undercut 17. It is then no longer possible to remove it non-destructively from the needle hub 7.
- the securing ring 15 is preferably formed by the choice of its wall thickness so that it can be easily widened when pushed onto the retaining ring 13, wherein finally the projection 19 elastically - seen in the direction of slipping - springs behind the undercut 21.
- the circlip 15 is then preferably under bias to the retaining ring 13, so that it is no longer possible to deduct it non-destructively again.
- the retaining ring 15 and the retaining ring 13 may be integrally formed. They are then not assembled as described, but form a single, one-piece element which is placed on the needle attachment piece 7.
- they can be manufactured as an integral element in an injection molding process. If they include the same material, a single injection molding step is sufficient. However, they can also comprise different materials, whereby they can then preferably be produced in a two-component injection molding process.
- the safety cap 11 and the closure cap 9 are also preferably produced in a two-component injection molding process as a one-piece element.
- the safety cap 11 and the snap ring 15 are made of the same material as a one-piece element in a single injection molding step.
- the at least one tear bar, which connects the two parts is also formed.
- the closure cap 9 is then preferably produced in a further injection molding step.
- the retaining ring 13 can be manufactured separately. But it is also possible to manufacture it preferably in the same injection molding step of the same material together with the safety cap 11 and the retaining ring 15.
- the entire closure 3 can be produced as a one-piece element in a multi-component injection molding process. He then just has to be pushed onto the needle hub piece 7 until the retaining ring 13 - seen in the direction of slipping - behind the undercut 17 snaps to close the syringe 1.
- Figure 2 shows a detailed view of the embodiment of the syringe 1 according to Figure 1 in longitudinal section in the closed state.
- the same and functionally identical elements are provided with the same reference numerals, so that reference is made to the preceding description.
- Figure 2 is darg Hormine that the retaining ring 15 in the present embodiment with the jump 19, the undercut 21 engages latching behind. Since the securing cap 11 is connected to the circlip 15 via the at least one breaker bar, it is indirectly fastened to the needle hub 7 via the retaining ring 13 because the circlip 15 is fastened to the retaining ring 13, which in turn is fastened to the needle hub 7 , in which he almost engages behind the undercut 17 latching.
- the needle hub 7 and the cap 9 are shown as overlapping, because in Figure 2, the deformation of the soft or elastic material of the cap 9 is not considered. From this representation, however, it is particularly clear that in fact the closure cap 9 is elastically deformed when placed on the needle hub 7, so that it rests sealingly against it. In particular, the projection 25 ensures a tight covering of the mouth 27.
- the method for producing a closure is explained in more detail below: First, either the safety cap 1 1 is injection molded from a first, preferably hard material, or the cap 9 is injection molded from a second, preferably soft material. Subsequently, either the cap 9 is sprayed onto the fuse cap 11, or the fuse cap 11 is sprayed onto the cap 9. In any case, both elements are preferably molded integrally into one another in a two-component injection molding process.
- the securing ring 15 is preferably also formed in the same multi-component injection-molding method. In particular, it is possible to mold it in the same injection molding step together with the safety cap 1 1, if it comprises the same material as this. At the same time, the at least one tear-off bar is also formed, which connects the two elements to one another.
- the closure cap 9 is then formed in accordance with the unit of fuse cap 11 and retaining ring 15, or this unit is formed on the cap 9.
- the retaining ring 13 is formed in the same multi-component injection molding process as the safety cap 11 and the closure cap 9.
- the safety cap 11, the retaining ring 15 and the retaining ring 13 in an injection molding step of the same material. Subsequently, the closure cap 9 can then be molded into this unit, or the unit can be molded onto the closure cap 9. This creates the closure 3 as a completely one-piece Element, which only has to be placed on the needle hub 7 to close the syringe 1.
- the retaining ring 15 and the retaining ring 13 in the same multi-component injection molding method as the safety cap 11 and the closure cap 9, but at least one additional injection molding step for forming the securing ring 15 and / or Provide retaining rings 13.
- the securing ring 15 and / or the retaining ring 13 of the fuse cap 11 and / or comprise different materials it is possible to form the retaining ring 15 and the retaining ring 13 in the same multi-component injection molding method as the safety cap 11 and the closure cap 9, but at least one additional injection molding step for forming the securing ring 15 and / or Provide retaining rings 13.
- the closure cap is preferably injection-molded from a material which comprises, preferably consists of, thermoplastic elastomer (TPE).
- TPE thermoplastic elastomer
- the safety cap 11 and the closure cap 9 are locked together during injection molding.
- at least one recess 29 is preferably provided on the closure cap 9, into which at least one projection 31 of the safety cap 11 engages. It is also possible to provide a recess on the securing cap 11 into which a corresponding projection of the Closure cap 9 engages. Finally, it is possible to provide on both elements at least one recess and at least one projection, which interlock latching.
- closure cap 9 and the securing cap 11 then comprise the corresponding latching means, namely projections and / or recesses.
- the at least one recess 29 and the at least one projection 31 are formed such that axial forces can be introduced from the securing cap 11 into the closure cap 9. This makes it possible that the cap 9 is taken when the safety cap 11 is separated and removed from the locking ring 15. To expose the needle hub 7 for use of the syringe 1, it is then not necessary to first remove the safety cap 11 and then the cap 9, but both elements are removed at the same time when the cap 11 is removed.
- the at least one projection 31 and the at least one recess 29 are formed such that forces acting in the circumferential direction can also be introduced from the securing cap 11 into the closure cap 9 or vice versa. As a result, a relative rotation between the safety cap 11 and the cap 9 is effectively prevented. This increases the tightness of the closure 3, because the closure cap 9 does not move in the safety cap 11, in particular can not be rotated.
- Preference is here - seen in the circumferential direction - a plurality of recesses 29 and projections 31, particularly preferably at the same angular distance from each other, is provided.
- the safety cap 11 and the closure cap 9 are formed as an integral element, and in particular the fact that the two elements are locked together, the overall height or extension - seen in the longitudinal or axial direction - of the closure 3 can be reduced. Namely, if these elements are formed in two pieces, the securing cap 11 not only has to cover over the cap 9 but also to protect it against loss or unauthorized removal or - in the axial direction - to stabilize it. If the elements, however, formed integrally with each other, in particular locked together, it is sufficient if the safety cap 11, the closure cap 9 - as seen in the circumferential direction - surrounds, as shown in Figure 1 and in Figure 2.
- cap 9 is accessible from above in the illustration of Figure 2, it can not be removed from the needle hub 7 as long as the safety cap 11 is connected to the retaining ring 15.
- the closure 3 can therefore - seen in the longitudinal direction - have a shorter extension or smaller overall height.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Closures For Containers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013555780A JP2014508601A (ja) | 2011-03-03 | 2012-02-23 | シリンジ用の密栓と製造方法 |
BR112013022563A BR112013022563A2 (pt) | 2011-03-03 | 2012-02-23 | fecho para uma seringa e processo de produção do mesmo |
EP12706468.1A EP2680908A1 (de) | 2011-03-03 | 2012-02-23 | Verschluss für eine spritze und herstellungsverfahren |
RU2013144355/14A RU2013144355A (ru) | 2011-03-03 | 2012-02-23 | Крышка для шприца и способ ее изготовления |
MX2013010047A MX2013010047A (es) | 2011-03-03 | 2012-02-23 | Cierre para jeringa y metodo de produccion de esta. |
US14/002,507 US20130338603A1 (en) | 2011-03-03 | 2012-02-23 | Closure for a syringe and method of producing same |
CA2828904A CA2828904A1 (en) | 2011-03-03 | 2012-02-23 | Closure for a syringe and method for producing same |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE201110013791 DE102011013791A1 (de) | 2011-03-03 | 2011-03-03 | Verschluss und Verfahren zur Herstellung eines Verschlusses |
DE102011013791.2 | 2011-03-03 | ||
DE102011107276 | 2011-07-15 | ||
DE102011107276.8 | 2011-07-15 | ||
DE201110111552 DE102011111552A1 (de) | 2011-03-03 | 2011-08-24 | Spritze, Verschluss für eine Spritze und Verfahren zum Herstellen eines Verschlusses |
DE102011111552.1 | 2011-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2012116790A1 true WO2012116790A1 (de) | 2012-09-07 |
Family
ID=46757371
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2012/000786 WO2012116791A1 (de) | 2011-03-03 | 2012-02-23 | Verschluss und verfahren zur herstellung eines verschlusses |
PCT/EP2012/000785 WO2012116790A1 (de) | 2011-03-03 | 2012-02-23 | Verschluss für eine spritze und herstellungsverfahren |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2012/000786 WO2012116791A1 (de) | 2011-03-03 | 2012-02-23 | Verschluss und verfahren zur herstellung eines verschlusses |
Country Status (8)
Country | Link |
---|---|
US (2) | US20130338603A1 (de) |
EP (2) | EP2680909A1 (de) |
JP (2) | JP2014508602A (de) |
BR (2) | BR112013022565A2 (de) |
CA (2) | CA2828904A1 (de) |
MX (2) | MX2013010047A (de) |
RU (2) | RU2013144355A (de) |
WO (2) | WO2012116791A1 (de) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012022359A1 (de) * | 2012-11-15 | 2014-05-15 | Vetter Pharma-Fertigung GmbH & Co. KG | Aufsatz für eine Spritze oder Karpule |
WO2014108262A1 (de) * | 2013-01-11 | 2014-07-17 | Vetter Pharma-Fertigung GmbH & Co. KG | Befestigungselement und spritze |
RU2638617C2 (ru) * | 2013-03-11 | 2017-12-14 | Феттер Фарма-Фертигунг Гмбх Унд Ко. Кг | Насадка для шприца, карпулы или подобного |
EP3342441A1 (de) | 2017-01-02 | 2018-07-04 | Schott AG | Spritze mit unterschiedlichen materialien |
EP3381492A1 (de) * | 2017-03-31 | 2018-10-03 | Schott Kaisha Private Limited | Spritzenspitzenkappenanordnung, spritze mit solch einer spritzenspitzenkappe und verfahren zur abdichtung eines spritzenzylinders |
US10258540B2 (en) | 2013-07-15 | 2019-04-16 | Becton Dickinson France | Adaptor for a drug delivery device and method for mounting said adaptor thereon |
WO2019123488A1 (en) * | 2017-12-19 | 2019-06-27 | Matex Lab S.P.A. | Cartridge for a syringe, and corresponding syringe |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2536825C1 (ru) | 2010-12-16 | 2014-12-27 | Бектон Дикинсон Франс | Адаптер и устройство для подачи лекарственного средства |
BR112013022565A2 (pt) * | 2011-03-03 | 2016-12-06 | Vetter Pharma Fertigung Gmbh & Co Kg | fecho e processo para a produção de um fecho |
KR102249043B1 (ko) * | 2012-09-26 | 2021-05-07 | 트란스코젝트 게엠베하 | 사전 충전된 주입기 |
US9597260B2 (en) * | 2013-03-15 | 2017-03-21 | Becton Dickinson and Company Ltd. | System for closed transfer of fluids |
EP2862587A1 (de) | 2013-10-15 | 2015-04-22 | Becton Dickinson France | Spitzenkappenanordnung zum Verschließen eines Injektionssystems |
JP1528650S (de) | 2014-06-20 | 2015-07-13 | ||
DE102014114403A1 (de) | 2014-10-02 | 2016-04-07 | Gerresheimer Regensburg Gmbh | Stopfen zum Aufsetzen auf ein Anschlusselement einer medizinischen Spritze |
FR3038228B1 (fr) * | 2015-06-30 | 2017-07-28 | Crossject | Dispositif d’injection sans aiguille a bouchon de fermeture positionnable angulairement |
CN108601910A (zh) | 2015-11-27 | 2018-09-28 | 赛诺菲-安万特德国有限公司 | 注射装置的部件、系统和方法 |
EP3189867B1 (de) * | 2016-01-06 | 2022-11-16 | Ypsomed AG | Verfahren zum herstellen von teilen und montieren von teilen an einer einspritzvorrichtung mit 2-komponentigem spritzgiessen |
EP3269418A1 (de) * | 2016-07-12 | 2018-01-17 | Becton Dickinson France | Spitzenkappenanorndung, medizinisches injektionssystem und verfahren zur herstellung eines medizinischen injektionssystems |
FR3063909B1 (fr) * | 2017-03-17 | 2022-03-11 | Biocorp Prod | Dispositif de protection d'aiguille pour une seringue pre-remplie a aiguille collee et seringue comprenant un tel dispositif |
USD862694S1 (en) | 2017-11-08 | 2019-10-08 | Schott Kaisha Pvt. Ltd | Syringe cap for sealing syringe for medical purpose |
EP3569272A1 (de) * | 2018-05-14 | 2019-11-20 | SCHOTT Schweiz AG | Verschluss für einen behälter für pharmazeutische präparate und mit diesem verschluss versehener behälter |
FR3084263B1 (fr) * | 2018-07-27 | 2020-07-10 | Laboratoire Aguettant | Systeme d’administration comportant un dispositif d’administration et un dispositif de protection pourvu d’une membrane de fermeture |
US11305072B2 (en) | 2018-11-28 | 2022-04-19 | Fresenius Kabi Usa, Llc | Tamper evident assembly for syringes |
EP3821925B1 (de) | 2019-09-18 | 2024-03-20 | KAISHA PACKAGING Private Ltd. | Vorrichtung zum verriegeln einer kolbenstange einer spritze nach gebrauch und zum verhindern der wiederverwendung der spritze und spritzenanordnung |
USD953368S1 (en) * | 2020-07-30 | 2022-05-31 | Sanofi | Display panel portion with an animated computer icon |
USD952675S1 (en) * | 2020-07-30 | 2022-05-24 | Sanofi | Display panel portion with an animated computer icon |
USD952674S1 (en) * | 2020-07-30 | 2022-05-24 | Sanofi | Display panel portion with an animated computer icon |
USD949195S1 (en) * | 2020-07-30 | 2022-04-19 | Sanofi | Display panel portion with an animated computer icon |
USD958834S1 (en) * | 2020-07-30 | 2022-07-26 | Sanofi | Display panel portion with an animated computer icon |
USD953366S1 (en) * | 2020-07-30 | 2022-05-31 | Sanofi | Display panel portion with an animated computer icon |
USD947889S1 (en) * | 2020-07-30 | 2022-04-05 | Sanofi | Display panel portion with an animated computer icon |
USD953367S1 (en) * | 2020-07-30 | 2022-05-31 | Sanofi | Display panel portion with an animated computer icon |
USD958183S1 (en) * | 2020-07-30 | 2022-07-19 | Sanofi | Display panel portion with an animated computer icon |
US12005238B2 (en) | 2020-10-20 | 2024-06-11 | Fresenius Kabi Usa, Llc | Impact resistant and tamper evident system for prefilled syringe |
USD1003307S1 (en) | 2020-10-30 | 2023-10-31 | Embecta Corp. | Display screen or portion thereof with a graphical user interface for an integrated disease management system |
USD966301S1 (en) * | 2021-02-25 | 2022-10-11 | Rightpoint Consulting, LLC | Display panel portion with an animated computer icon |
USD966304S1 (en) * | 2021-02-25 | 2022-10-11 | Rightpoint Consulting, LLC | Display panel portion with an animated computer icon |
USD969843S1 (en) * | 2021-02-25 | 2022-11-15 | Rightpoint Consulting, LLC | Display panel portion with an animated computer icon |
USD965624S1 (en) * | 2021-02-25 | 2022-10-04 | Rightpoint Consulting, LLC | Display panel portion with an animated computer icon |
USD1039567S1 (en) * | 2021-09-06 | 2024-08-20 | Roche Diabetes Care, Inc. | Display screen or portion thereof with a graphical user interface |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19909824A1 (de) * | 1999-03-05 | 2000-09-07 | Vetter & Co Apotheker | Spritze für medizinische Zwecke und Verfahren zu ihrer Montage |
US6520935B1 (en) * | 1994-12-12 | 2003-02-18 | Becton, Dickinson And Company | Syringe and tip cap assembly |
EP1410819A1 (de) * | 2002-10-15 | 2004-04-21 | TRANSCOJECT GESELLSCHAFT FÜR MEDIZINISCHE GERÄTE mbH & CO. KG | Originalitätsverschluss für eine Spritze |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0397951B1 (de) * | 1989-05-17 | 1994-07-20 | Arzneimittel GmbH Apotheker Vetter & Co. Ravensburg | Spritze für medizinische Zwecke |
US5624402A (en) * | 1994-12-12 | 1997-04-29 | Becton, Dickinson And Company | Syringe tip cap |
US5807345A (en) * | 1995-06-30 | 1998-09-15 | Abbott Laboratories | Luer cap for terminally sterilized syringe |
JP3828951B2 (ja) * | 1995-12-22 | 2006-10-04 | リケンテクノス株式会社 | 医療用栓 |
DE19652708C2 (de) * | 1996-12-18 | 1999-08-12 | Schott Glas | Verfahren zum Herstellen eines befüllten Kunststoff-Spritzenkorpus für medizinische Zwecke |
MXPA00011767A (es) * | 1998-05-29 | 2002-10-17 | Lawrence A Lynn | Receptor luer y metodos para transferir fluidos. |
DE19950039C1 (de) * | 1999-10-16 | 2001-04-26 | Bayerische Motoren Werke Ag | Herstellverfahren für ein aus zumindest zwei Komponenten bestehendes Kunststoff-Spritzguß-Bauteil |
DE19954373B4 (de) * | 1999-11-11 | 2011-01-27 | Helvoet Pharma Belgium N.V. | Schutzkappe für eine Kanüle |
JP3591636B2 (ja) * | 2000-04-03 | 2004-11-24 | ニプロ株式会社 | プレフィルドシリンジ |
US6193688B1 (en) * | 2000-07-17 | 2001-02-27 | Bracco Diagnostics, Inc. | Tamper evident protector cap for pre-filled syringe barrels |
DE102005054075A1 (de) * | 2005-11-12 | 2007-05-16 | Vetter & Co Apotheker | Kanülenaufsatz für eine Spritze oder Karpule |
BR112013022565A2 (pt) * | 2011-03-03 | 2016-12-06 | Vetter Pharma Fertigung Gmbh & Co Kg | fecho e processo para a produção de um fecho |
-
2012
- 2012-02-23 BR BR112013022565A patent/BR112013022565A2/pt not_active IP Right Cessation
- 2012-02-23 US US14/002,507 patent/US20130338603A1/en not_active Abandoned
- 2012-02-23 BR BR112013022563A patent/BR112013022563A2/pt not_active IP Right Cessation
- 2012-02-23 MX MX2013010047A patent/MX2013010047A/es not_active Application Discontinuation
- 2012-02-23 MX MX2013009991A patent/MX2013009991A/es not_active Application Discontinuation
- 2012-02-23 EP EP12709011.6A patent/EP2680909A1/de not_active Withdrawn
- 2012-02-23 RU RU2013144355/14A patent/RU2013144355A/ru not_active Application Discontinuation
- 2012-02-23 CA CA2828904A patent/CA2828904A1/en not_active Abandoned
- 2012-02-23 CA CA2828919A patent/CA2828919A1/en not_active Abandoned
- 2012-02-23 RU RU2013144348/14A patent/RU2013144348A/ru not_active Application Discontinuation
- 2012-02-23 WO PCT/EP2012/000786 patent/WO2012116791A1/de active Application Filing
- 2012-02-23 US US14/002,535 patent/US20130338604A1/en not_active Abandoned
- 2012-02-23 WO PCT/EP2012/000785 patent/WO2012116790A1/de active Application Filing
- 2012-02-23 EP EP12706468.1A patent/EP2680908A1/de not_active Withdrawn
- 2012-02-23 JP JP2013555781A patent/JP2014508602A/ja active Pending
- 2012-02-23 JP JP2013555780A patent/JP2014508601A/ja not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6520935B1 (en) * | 1994-12-12 | 2003-02-18 | Becton, Dickinson And Company | Syringe and tip cap assembly |
DE19909824A1 (de) * | 1999-03-05 | 2000-09-07 | Vetter & Co Apotheker | Spritze für medizinische Zwecke und Verfahren zu ihrer Montage |
EP1410819A1 (de) * | 2002-10-15 | 2004-04-21 | TRANSCOJECT GESELLSCHAFT FÜR MEDIZINISCHE GERÄTE mbH & CO. KG | Originalitätsverschluss für eine Spritze |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102012022359A1 (de) * | 2012-11-15 | 2014-05-15 | Vetter Pharma-Fertigung GmbH & Co. KG | Aufsatz für eine Spritze oder Karpule |
US9764098B2 (en) | 2012-11-15 | 2017-09-19 | Vetter Pharma-Fertigung GmbH & Co. KG | Attachment for a syringe or carpule |
WO2014108262A1 (de) * | 2013-01-11 | 2014-07-17 | Vetter Pharma-Fertigung GmbH & Co. KG | Befestigungselement und spritze |
US10369297B2 (en) | 2013-01-11 | 2019-08-06 | Vetter Pharma-Fertigung GmbH & Co. KG | Fastening element and syringe |
RU2638617C2 (ru) * | 2013-03-11 | 2017-12-14 | Феттер Фарма-Фертигунг Гмбх Унд Ко. Кг | Насадка для шприца, карпулы или подобного |
US10258540B2 (en) | 2013-07-15 | 2019-04-16 | Becton Dickinson France | Adaptor for a drug delivery device and method for mounting said adaptor thereon |
EP3342441A1 (de) | 2017-01-02 | 2018-07-04 | Schott AG | Spritze mit unterschiedlichen materialien |
DE102017200007A1 (de) * | 2017-01-02 | 2018-07-05 | Schott Ag | Spritze mit unterschiedlichen Materialien |
EP3381492A1 (de) * | 2017-03-31 | 2018-10-03 | Schott Kaisha Private Limited | Spritzenspitzenkappenanordnung, spritze mit solch einer spritzenspitzenkappe und verfahren zur abdichtung eines spritzenzylinders |
WO2019123488A1 (en) * | 2017-12-19 | 2019-06-27 | Matex Lab S.P.A. | Cartridge for a syringe, and corresponding syringe |
Also Published As
Publication number | Publication date |
---|---|
EP2680908A1 (de) | 2014-01-08 |
RU2013144355A (ru) | 2015-04-10 |
EP2680909A1 (de) | 2014-01-08 |
US20130338603A1 (en) | 2013-12-19 |
CA2828904A1 (en) | 2012-09-07 |
RU2013144348A (ru) | 2015-04-10 |
JP2014508602A (ja) | 2014-04-10 |
WO2012116791A1 (de) | 2012-09-07 |
BR112013022565A2 (pt) | 2016-12-06 |
CA2828919A1 (en) | 2012-09-07 |
US20130338604A1 (en) | 2013-12-19 |
JP2014508601A (ja) | 2014-04-10 |
MX2013009991A (es) | 2014-03-27 |
MX2013010047A (es) | 2014-01-31 |
BR112013022563A2 (pt) | 2016-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2680908A1 (de) | Verschluss für eine spritze und herstellungsverfahren | |
EP1600190B1 (de) | Spritzenverschluss und Verfahren zum Herstellen eines Spritzenverschlusses | |
EP2900301B1 (de) | Vorgefüllte spritze | |
EP1410819B1 (de) | Originalitätsverschluss für eine Spritze | |
DE102006040888B3 (de) | Verschlusssystem für Behältnisse | |
DE102008009418B3 (de) | Verschlusskappe | |
EP2916894B1 (de) | Spritzenverschluss | |
EP1951343B1 (de) | Aufsatz für eine spritze oder karpule | |
WO2009109312A1 (de) | Orginalitätsverschluss mit haltezapfen | |
DE2909002B2 (de) | Injektionsspritze für einmalige Verwendung | |
EP2788058A2 (de) | Verschluss, insbesondere spritzenverschluss zum abdichtenden verschliessen einer distalen öffnung eines spritzenkörpers | |
DE102011111552A1 (de) | Spritze, Verschluss für eine Spritze und Verfahren zum Herstellen eines Verschlusses | |
DE102011013791A1 (de) | Verschluss und Verfahren zur Herstellung eines Verschlusses | |
EP1410817A1 (de) | Spritzenzylinder | |
DE102016219889B4 (de) | Dichtring | |
EP2607252B1 (de) | Anordnung eines Behältnisses aus Röhrenglas und eines einteiligen Verschlusses für den Behälter | |
DE102016118767A1 (de) | Verfahren zum Herstellen einer Spritze mit einem integrierten Verschlusselement | |
EP1154812B1 (de) | Spritzeneinrichtung | |
DE202016101947U1 (de) | Verbindungsvorrichtung zur Verbindung einer medizinischen Schlauchleitung mit einer Flasche | |
EP0060983B1 (de) | Behälter mit Sicherheitsverschluss | |
DE202013011561U1 (de) | Verschluss-System, insbesondere Spritzenverschluss und Behälter fürpharmazeutische Präparate, insbesondere Spritze für medizinische Zwecke | |
EP3807163B1 (de) | Verfahren zur herstellung eines sicherheitsverschlusses sowie spritzling und sicherheitsverschluss | |
AT525541A4 (de) | Aufnahmeeinrichtung mit Septum und Verfahren zu dessen Herstellung | |
WO2023067079A1 (de) | Verschluss für einen medizinischen hohlkörper, medizinischer hohlkörper mit einem solchen verschluss und verfahren zur herstellung eines solchen verschlusses | |
EP4419174A1 (de) | Verschluss für einen medizinischen hohlkörper, medizinischer hohlkörper mit einem solchen verschluss und verfahren zur herstellung eines solchen verschlusses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12706468 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012706468 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14002507 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2013555780 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2013/010047 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2828904 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2013144355 Country of ref document: RU Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112013022563 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112013022563 Country of ref document: BR Kind code of ref document: A2 Effective date: 20130903 |